Clinical Trial Update: Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating gemcitabine with radiation therapy or combination chemotherapy for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED